Olanzapine for Prevention of Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy

NCT07035821 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Breakthrough Chemotherapy-Induced Vomiting (CIV) in Pediatric Patients
Pediatric Cancer

Interventions

DRUG: Olanzapine Tablets
DRUG: Placebo

Sponsor

Shanghai Children's Medical Center